3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pain
11
Neoplasms
7
Cancer Pain
5
Pain, Postoperative
2
Pain, Intractable
2
Lymphoma, Follicular
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Vomiting
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stomatitis
1
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Surgery
1
Sleep Wake Disorders
1
Signs and Symptoms
1
Sezary Syndrome
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pathologic Processes
1
Pain Related to Cancer
1
Opioid-Related Disorders
1
Neurologic Manifestations
1
Interventions
pembrolizumab
3
Pemetrexed
2
Cholecalciferol
2
relacorilant
1
glutathione pegylated liposomal doxorubicin
1
ficlatuzumab
1
bosutinib
1
Trastuzumab
1
Sunitinib
1
Morphine
1
Methadone
1
MRX-2843
1
Letrozole
1
Imatinib Mesylate
1
Electrochemotherapy
1
Control Groups
1
Clomiphene
1
Cisplatin
1
Carboplatin
1
Bleomycin
1
Bevacizumab
1
Azacitidine
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pathologic Processes
×
Methadone
×
Clear all
NCT04475029
2023-09-13
METAMORF
University of Aarhus
Phase NA
Completed
114 enrolled